Results 231 to 240 of about 694,423 (327)

A new electronic test for the assessment of hepatic encephalopathy at home

open access: bronze, 2000
Andreas D. Christ   +4 more
openalex   +1 more source

Low‐Dose Hydrocortisone in Cirrhotic Patients With Septic Shock: A Double‐Blind Randomised Placebo‐Controlled Trial

open access: yesLiver International, Volume 45, Issue 9, September 2025.
ABSTRACT Background and Aims Steroid supplementation remains controversial in septic shock, partly due to the heterogeneity of the populations studied. Cirrhotic patients with sepsis frequently develop relative adrenal insufficiency, showing poor response to vasopressors and poor prognosis.
Philippe Meersseman   +16 more
wiley   +1 more source

Branched-chain amino acids for people with hepatic encephalopathy.

open access: yesCochrane Database of Systematic Reviews, 2017
L. Gluud   +6 more
semanticscholar   +1 more source

Assessment of PBC Pruritus From the ITCH‐E Study: Quality of Life, Productivity, and Treatment Experiences

open access: yesLiver International, Volume 45, Issue 9, September 2025.
ABSTRACT Background & Aims This US‐based study assessed the impact of pruritus on health‐related quality of life (HRQoL) and treatment experiences of people with primary biliary cholangitis (PBC). Methods Patients with PBC were recruited from a physician panel and patient advocacy group. Participants were grouped by the Pruritus Numerical Rating Scale (
Cynthia Levy   +9 more
wiley   +1 more source

Assessment of metabolic dysfunction‐associated fatty liver disease in primary care: a consensus statement summary

open access: yesMedical Journal of Australia, Volume 223, Issue 5, Page 268-276, September 2025.
Abstract Introduction Metabolic dysfunction‐associated fatty liver disease (MAFLD) is common. This evidence‐based consensus statement summary provides recommendations for the assessment and monitoring of adults with MAFLD in primary care. Main recommendations Adults with type 2 diabetes, obesity or two or more other metabolic risk factors should be ...
Leon A Adams   +15 more
wiley   +1 more source

Patient‐derived tumor organoids highlight the potential of precision medicine in managing pancreatic ductal adenocarcinoma

open access: yesInternational Journal of Cancer, Volume 157, Issue 4, Page 760-772, 15 August 2025.
What's new? Only about one‐fifth of patients with pancreatic ductal adenocarcinoma (PDAC) qualify for curative treatment approaches employing adjuvant chemotherapy. Tools to predict PDAC response to chemotherapeutic regimens, however, are lacking.
Christine Nitschke   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy